Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review.
ESCMID Study Group for Infections in Travellers and Migrants
MetadataShow full item record
JournalJournal of migration and health
AbstractBackground: Migrants in high-income countries may be at increased risk of COVID-19 due to their health and social circumstances, yet the extent to which they are affected and their predisposing risk factors are not clearly understood. We did a systematic review to assess clinical outcomes of COVID-19 in migrant populations, indirect health and social impacts, and to determine key risk factors. Methods: We did a systematic review following PRISMA guidelines (PROSPERO CRD42020222135). We searched multiple databases to 18/11/2020 for peer-reviewed and grey literature on migrants (foreign-born) and COVID-19 in 82 high-income countries. We used our international networks to source national datasets and grey literature. Data were extracted on primary outcomes (cases, hospitalisations, deaths) and we evaluated secondary outcomes on indirect health and social impacts and risk factors using narrative synthesis. Results: 3016 data sources were screened with 158 from 15 countries included in the analysis (35 data sources for primary outcomes: cases , hospitalisations ; deaths ; 123 for secondary outcomes). We found that migrants are at increased risk of infection and are disproportionately represented among COVID-19 cases. Available datasets suggest a similarly disproportionate representation of migrants in reported COVID-19 deaths, as well as increased all-cause mortality in migrants in some countries in 2020. Undocumented migrants, migrant health and care workers, and migrants housed in camps have been especially affected. Migrants experience risk factors including high-risk occupations, overcrowded accommodation, and barriers to healthcare including inadequate information, language barriers, and reduced entitlement. Conclusions: Migrants in high-income countries are at high risk of exposure to, and infection with, COVID-19. These data are of immediate relevance to national public health and policy responses to the pandemic. Robust data on testing uptake and clinical outcomes in migrants, and barriers and facilitators to COVID-19 vaccination, are urgently needed, alongside strengthening engagement with diverse migrant groups.
- Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
- Authors: Osborne SR, Alston LV, Bolton KA, Whelan J, Reeve E, Wong Shee A, Browne J, Walker T, Versace VL, Allender S, Nichols M, Backholer K, Goodwin N, Lewis S, Dalton H, Prael G, Curtin M, Brooks R, Verdon S, Crockett J, Hodgins G, Walsh S, Lyle DM, Thompson SC, Browne LJ, Knight S, Pit SW, Jones M, Gillam MH, Leach MJ, Gonzalez-Chica DA, Muyambi K, Eshetie T, Tran K, May E, Lieschke G, Parker V, Smith A, Hayes C, Dunlop AJ, Rajappa H, White R, Oakley P, Holliday S
- Issue date: 2020 Dec
- Strategies and action points to ensure equitable uptake of COVID-19 vaccinations: A national qualitative interview study to explore the views of undocumented migrants, asylum seekers, and refugees.
- Authors: Deal A, Hayward SE, Huda M, Knights F, Crawshaw AF, Carter J, Hassan OB, Farah Y, Ciftci Y, Rowland-Pomp M, Rustage K, Goldsmith L, Hartmann M, Mounier-Jack S, Burns R, Miller A, Wurie F, Campos-Matos I, Majeed A, Hargreaves S, ESCMID Study Group for Infections in Travellers and Migrants (ESGITM).
- Issue date: 2021
- How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.
- Authors: Seedat F, Hargreaves S, Nellums LB, Ouyang J, Brown M, Friedland JS
- Issue date: 2018 Sep
- Sharpening our public health lens: advancing im/migrant health equity during COVID-19 and beyond.
- Authors: Machado S, Goldenberg S
- Issue date: 2021 Feb 8
- Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.
- Authors: Rustage K, Lobe J, Hayward SE, Kristensen KL, Margineanu I, Stienstra Y, Goletti D, Zenner D, Noori T, Pareek M, Greenaway C, Friedland JS, Nellums LB, Hargreaves S, ESGITM and ESGMYC study groups.
- Issue date: 2021 Aug 4